Personalizing Your Treatment Plan
At a Glance
Treatment for audiogenic epilepsy is individualized: medicines and trigger management are common first steps, while persistent seizures may require epilepsy-center evaluation for surgery, immunotherapy, or neuromodulation based on MRI, EEG, GAD65 antibody results, and seizure focus.
Treating sound-triggered epilepsy requires a personalized approach that addresses the unique way your brain reacts to sound. Because these seizures are typically focal—meaning they start in one specific area—treatment focuses on stabilizing that area or identifying the underlying reason for its sensitivity [1][2].
First-Line Management: Medication and Avoidance
The first step in management usually involves a combination of lifestyle adjustments and medication.
- Trigger Avoidance: For some people, identifying and avoiding a very specific trigger (such as a single song or a specific ringtone) can reduce events [3][4]. However, because music is so common in daily life, avoidance does not prove seizure freedom or eliminate the need for medical treatment [3].
- Anti-Seizure Medications (ASMs): Doctors typically prescribe medications used for focal epilepsy. Options often include lamotrigine, levetiracetam, lacosamide, or oxcarbazepine [5][2]. Selection depends on the confirmed seizure type, comorbidities, interactions, and adverse effects. Patients should not stop an antiseizure medicine abruptly.
- A Note for Musicians: Some medications, specifically carbamazepine and oxcarbazepine, can temporarily change how you perceive musical pitch [6][7]. If you are a musician or your work involves music, be sure to discuss these potential side effects with your neurologist.
When Medication Isn’t Enough
If you have tried two appropriately selected, adequately dosed, tolerated, and adhered-to medication regimens and continue to have seizures, your condition may be considered drug-resistant (after the diagnosis of epileptic seizures has been established) [2][8]. At this point, a referral to a comprehensive epilepsy center is appropriate to explore advanced options [9].
The Treatment Decision Tree
The “best” treatment depends heavily on what is causing the seizures. Your medical team will use MRI and EEG results to determine which path you follow:
Path 1: Structural or Focal Causes
If your seizures consistently start in one small, identifiable area (like a scar or a small malformation in one temporal lobe), you may be a candidate for procedures designed to stop the seizure at its source [1][10]. This requires concordant multimodal presurgical testing rather than MRI and EEG alone.
- Resective Surgery: This involves removing the specific piece of brain tissue where the seizures start. It has led to long-term seizure freedom in several reported cases of musicogenic epilepsy [11][12].
- Laser Interstitial Thermal Therapy (LITT): This is a newer, less invasive option. A surgeon uses a tiny laser fiber to heat and destroy the seizure-producing tissue [13]. LITT carries procedure-specific risks that must be carefully evaluated.
- When Surgery is Not an Option: Surgery may be discouraged if seizures start in “eloquent” areas (parts of the brain vital for speech or movement) or if they start on both sides of the brain (bilateral onset) [14][13].
Path 2: Autoimmune Causes (e.g., GAD65 Positive)
If your blood or spinal fluid tests positive for high levels of GAD65 antibodies, your seizures may be caused by an overactive immune system affecting the brain [3].
- Immunotherapy: Instead of (or in addition to) surgery, your doctor may recommend treatments like IVIG (intravenous immunoglobulin) or high-dose corticosteroids to calm the immune response [3][15]. A positive result does not automatically justify immunotherapy; responses are variable.
- Surgical Caution: Research shows that people with GAD65 antibodies often have seizure activity on both sides of the brain, which can make traditional surgery less successful and requires individualized multidisciplinary assessment [3][15].
Managing Complex Cases
In cases where neither surgery nor immunotherapy is fully effective, or if seizures are widespread, other options like neuromodulation (devices that use electrical pulses to disrupt seizure patterns) may be considered [16]. The goal of any treatment plan is “shared decision-making,” where you and your care team weigh the risks of the seizures against the potential side effects of treatment to maintain your quality of life [16][5].
Common questions in this guide
What is the usual first treatment for audiogenic epilepsy?
When is sound-triggered epilepsy considered drug-resistant?
Could surgery or LITT stop my audiogenic seizures?
What does a positive GAD65 antibody test mean for treatment?
Can anti-seizure medicines change how I hear music?
What treatments are available if seizures start in both sides of the brain?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Audiogenic epilepsy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Am I a candidate for referral to a Level 3 or 4 Comprehensive Epilepsy Center for a full surgical evaluation?
- 2.If my seizures don't respond to two different medications, what is the next step in my treatment plan?
- 3.Should I be tested for GAD65 antibodies, and how would a positive result change our approach to my treatment?
- 4.How do you weigh the benefits of a procedure like Laser Interstitial Thermal Therapy (LITT) versus a traditional resection for my specific seizure focus?
- 5.Are there specific anti-seizure medications that are less likely to affect my musical perception or hearing?
- 6.If my seizures are coming from both sides of my brain (bilateral), what neuromodulation or alternative therapies are available to me?
References
References (16)
- 1
- 2
Focal epilepsies: Update on diagnosis and classification.
Nascimento FA, Friedman D, Peters JM, et al.
Epileptic disorders : international epilepsy journal with videotape 2023; (25(1)):1-17 doi:10.1002/epd2.20045.
PMID: 36938903 - 3
Musicogenic epilepsy: Expanding the spectrum of glutamic acid decarboxylase 65 neurological autoimmunity.
Smith KM, Zalewski NL, Budhram A, et al.
Epilepsia 2021; (62(5)):e76-e81 doi:10.1111/epi.16888.
PMID: 33764529 - 4
Successful treatment of reflex epilepsy with praxis induction by stimulus avoidance only.
Tan ZR, Tian FF, Long XY, et al.
Epilepsy & behavior : E&B 2018; (86()):163-165 doi:10.1016/j.yebeh.2018.04.030.
PMID: 30037584 - 5
Update on Antiseizure Medications 2025.
Abou-Khalil BW
Continuum (Minneapolis, Minn.) 2025; (31(1)):125-164 doi:10.1212/CON.0000000000001521.
PMID: 39899099 - 6
Music and its association with epileptic disorders.
Maguire M
Progress in brain research 2015; (217()):107-27.
PMID: 25725912 - 7
Epilepsy and music: practical notes.
Maguire M
Practical neurology 2017; (17(2)):86-95 doi:10.1136/practneurol-2016-001487.
PMID: 27903764 - 8
Resective focal epilepsy surgery - Has selection of candidates changed? A systematic review.
Kwon CS, Neal J, Telléz-Zenteno J, et al.
Epilepsy research 2016; (122()):37-43.
PMID: 26921855 - 9
Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies.
Guery D, Rheims S
Neuropsychiatric disease and treatment 2021; (17()):2229-2242 doi:10.2147/NDT.S256699.
PMID: 34285484 - 10
Musicogenic epilepsy: A Stereo-electroencephalography study.
Pelliccia V, Villani F, Gozzo F, et al.
Cortex; a journal devoted to the study of the nervous system and behavior 2019; (120()):582-587 doi:10.1016/j.cortex.2019.02.005.
PMID: 30837152 - 11
Musicogenic seizures in temporal lobe epilepsy: Case reports based on ictal source localization analysis.
Bratu IF, Nica AE, Oane I, et al.
Frontiers in neurology 2023; (14()):1072075 doi:10.3389/fneur.2023.1072075.
PMID: 36891471 - 12
Localization of musicogenic epilepsy to Heschl's gyrus and superior temporal plane: case report.
Nagahama Y, Kovach CK, Ciliberto M, et al.
Journal of neurosurgery 2018; (129(1)):157-164.
PMID: 28946181 - 13
Laser ablative treatment of musicogenic epilepsy arising from dominant mesial temporal lobe: illustrative case.
Park C, Sinha SR, Southwell DG
Journal of neurosurgery. Case lessons 2022; (3(23)):CASE2295.
PMID: 35733825 - 14
Anti-GAD65 musicogenic epilepsy: Bilateral and independent mesial temporal seizures revealed by foramen ovale electrodes.
Di Giacomo R, Maccanti G, Gnatkovsky V, et al.
Epilepsia open 2025; (10(2)):609-614 doi:10.1002/epi4.13132.
PMID: 39835722 - 15
Drug-resistant glutamic acid decarboxylase 65-associated epilepsy: Pre-surgical evaluation and comparison to temporal lobe epilepsy of other etiology.
Thomsen AN, Ortiz-Guerrero G, Dubey D, et al.
Epilepsia 2026; (67(2)):e23-e31 doi:10.1002/epi.70068.
PMID: 41474363 - 16
Current challenges in focal epilepsy treatment: An Italian Delphi consensus.
Di Gennaro G, Lattanzi S, Mecarelli O, et al.
Epilepsy & behavior : E&B 2024; (155()):109796 doi:10.1016/j.yebeh.2024.109796.
PMID: 38643659
This page is for informational purposes only and does not constitute medical advice. Do not change or stop medication or pursue testing or procedures without discussing your situation with a neurologist or comprehensive epilepsy team.